Melanoma: Diagnosis & Treatment at Memorial Sloan Kettering

Pictured: Jedd Wolchok We're finding new melanoma treatments. Medical oncologist Jedd Wolchok headed a clinical trial that led to FDA approval of the first drug to work against melanoma after it has metastasized.

Memorial Sloan Kettering's multidisciplinary Melanoma Disease Management Team includes experts who focus exclusively on diagnosing and treating all forms of melanoma. Our team delivers highly coordinated care to approximately 1,000 new patients with melanoma each year.

Pictured: Paul Chapman

Medical experts from Memorial Sloan Kettering discuss new strategies for preventing, diagnosing, and treating skin cancer.


We meet weekly to review the cases and treatment plans of our patients. When necessary, our team collaborates with additional specialists to treat melanoma that has metastasized, or spread, to other parts of the body, such as the lungs, bones, or brain. We also have experts who provide psychosocial support to melanoma patients and their caregivers throughout treatment.

Our melanoma treatment program is complemented by our extensive research efforts to improve survival for patients with this disease. Because many of our doctors also engage in clinical research, patients at Memorial Sloan Kettering have access to new diagnostic and therapeutic techniques that are not widely available at other hospitals.